ReviewEndocrine, metabolic & immune disorders drug targets2026
The Gut-Joint Axis in Osteoarthritis: A Bibliometric Analysis of Research Trends and Mechanistic Insights (2008-2025).
Review in Endocrine, metabolic & immune disorders drug targets, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionOsteoarthritis (OA) is a leading cause of disability, and emerging evidence highlights the gut-joint axis as critical in its pathogenesis and therapy. To date, no bibliometric synthesis has comprehensively mapped this field.
methodsWe searched the Web of Science Core Collection (2008-2025) for original studies on gut microbiota and OA. Bibliometric and network analyses were performed using bibliometrix (R) and VOSviewer to assess publication trends, citations, collaborations, and research themes.
resultsA total of 175 original articles were identified, with a marked rise in research activity after 2015 and an accelerated growth post-2021. China and the United States are the leading contributors, with China exhibiting the most extensive international collaborations. The University of Calgary and Central South University emerged as top institutions, while journals, such as Osteoarthritis and Cartilage, demonstrated high impact. Thematic analysis revealed seven major research clusters, emphasizing systemic inflammation, metabolic risk factors, molecular mechanisms, and therapeutic strategies targeting the gut-joint axis. Recent years have seen a shift toward translational and mechanistic studies, with increased focus on molecular markers, clinical trials, and precision interventions. DISCUSSION: The results demonstrate a transition from descriptive and preclinical studies to mechanistic and clinical investigations. Collaborative networks across North America, Europe, and Asia have accelerated progress, but research remains uneven across regions.
conclusionThis bibliometric analysis underscores the rapid expansion of gut microbiota-OA research, highlighting microbial imbalance as a promising therapeutic target. Future work should integrate multi-omics, clinical trials, and global collaboration to advance precision strategies for OA management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.